NEW YORK – A promising multiple sclerosis drug that was suspended from the market because three people developed a rare brain disease now appears relatively safe and quite effective, three studies found. The research in Thursday’s New England Journal of Medicine comes days before government… Read More
Comments for: Studies back maligned MS drug
Studies back maligned MS drug
You may also like
Studies back maligned MS drug